DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹5,674 Cr | ₹4,643 Cr | ₹4,543 Cr | ₹5,888 Cr | ₹2,811 Cr |
What is the latest Cash Flow from Operating Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹5,674 Cr |
| Mar2025 | ₹4,643 Cr |
| Mar2024 | ₹4,543 Cr |
| Mar2023 | ₹5,888 Cr |
| Mar2022 | ₹2,811 Cr |
How is Cash Flow from Operating Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,674 Cr | 22.20 | |
| Mar2025 | ₹4,643 Cr | 2.19 | |
| Mar2024 | ₹4,543 Cr | -22.83 | |
| Mar2023 | ₹5,888 Cr | 109.46 | |
| Mar2022 | ₹2,811 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹95,969.6 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| MANKIND PHARMA | ₹94,531.6 Cr | -0.8% | -5.4% | -12.1% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.2% |
-4.4% |
-10.2% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses